JP2012514579A5 - - Google Patents

Download PDF

Info

Publication number
JP2012514579A5
JP2012514579A5 JP2011543955A JP2011543955A JP2012514579A5 JP 2012514579 A5 JP2012514579 A5 JP 2012514579A5 JP 2011543955 A JP2011543955 A JP 2011543955A JP 2011543955 A JP2011543955 A JP 2011543955A JP 2012514579 A5 JP2012514579 A5 JP 2012514579A5
Authority
JP
Japan
Prior art keywords
soft tissue
combination
botulinum toxin
injured
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011543955A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012514579A (ja
JP5688031B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2010/000008 external-priority patent/WO2010078648A1/en
Publication of JP2012514579A publication Critical patent/JP2012514579A/ja
Publication of JP2012514579A5 publication Critical patent/JP2012514579A5/ja
Application granted granted Critical
Publication of JP5688031B2 publication Critical patent/JP5688031B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011543955A 2009-01-07 2010-01-06 ヒアルロン酸およびボツリヌス毒素を使用する軟組織傷害の治療 Active JP5688031B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14294109P 2009-01-07 2009-01-07
US61/142,941 2009-01-07
PCT/CA2010/000008 WO2010078648A1 (en) 2009-01-07 2010-01-06 Treatment of soft tissue injury using hyaluronic acid and botulinum toxin

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014161022A Division JP2014208705A (ja) 2009-01-07 2014-08-07 ヒアルロン酸およびボツリヌス毒素を使用する軟組織傷害の治療

Publications (3)

Publication Number Publication Date
JP2012514579A JP2012514579A (ja) 2012-06-28
JP2012514579A5 true JP2012514579A5 (enExample) 2013-02-21
JP5688031B2 JP5688031B2 (ja) 2015-03-25

Family

ID=42311846

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011543955A Active JP5688031B2 (ja) 2009-01-07 2010-01-06 ヒアルロン酸およびボツリヌス毒素を使用する軟組織傷害の治療
JP2014161022A Withdrawn JP2014208705A (ja) 2009-01-07 2014-08-07 ヒアルロン酸およびボツリヌス毒素を使用する軟組織傷害の治療

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014161022A Withdrawn JP2014208705A (ja) 2009-01-07 2014-08-07 ヒアルロン酸およびボツリヌス毒素を使用する軟組織傷害の治療

Country Status (7)

Country Link
US (1) US9072779B2 (enExample)
EP (1) EP2381956B9 (enExample)
JP (2) JP5688031B2 (enExample)
AU (1) AU2010204445B2 (enExample)
CA (1) CA2749034C (enExample)
ES (1) ES2538835T3 (enExample)
WO (1) WO2010078648A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9044477B2 (en) * 2007-12-12 2015-06-02 Allergan, Inc. Botulinum toxin formulation
PT3019177T (pt) * 2013-07-10 2020-12-30 Matrix Biology Inst Composições de hialuronano de elevada elasticidade e suas utilizações
US9480731B2 (en) 2013-12-12 2016-11-01 Medy-Tox, Inc. Long lasting effect of new botulinum toxin formulations
EP3100756A4 (en) * 2014-01-31 2017-10-11 Terumo Kabushiki Kaisha Puncture aid and puncture instrument set
CN113577097A (zh) 2015-09-24 2021-11-02 基质生物研究所 高弹性透明质酸组合物及其使用方法
AU2017227978B2 (en) * 2016-03-02 2022-03-10 Merz Pharma Gmbh & Co. Kgaa Composition comprising botulinum toxin
US11623000B2 (en) * 2017-05-24 2023-04-11 Atgc Co., Ltd. Pharmaceutical composition for treating foot pain disease including botulinum toxin and hyaluronic acid, and foot pain disease treatment method using same
US11952601B2 (en) 2017-06-20 2024-04-09 Merz Pharma Gmbh & Co. Kgaa Recombinant botulinum toxin with increased duration of effect
ES2930237T3 (es) 2017-07-06 2022-12-09 Merz Pharma Gmbh & Co Kgaa Neurotoxinas botulínicas recombinantes nuevas con mayor duración de efectos
US20210000910A1 (en) 2019-07-03 2021-01-07 Jysk Skin Solutions Pte Ltd Topical compositions
US12083204B2 (en) 2022-06-02 2024-09-10 L'oreal Topical composition for homeostatic delivery of nitric oxide and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6423319B1 (en) 2000-10-04 2002-07-23 Allergan Sales, Inc. Methods for treating muscle injuries
US7300412B2 (en) * 2002-05-10 2007-11-27 Hospital For Joint Diseases Methods for therapeutic treatment of carpal tunnel syndrome
US7691394B2 (en) * 2002-05-28 2010-04-06 Botulinum Toxin Research Associates, Inc. High-potency botulinum toxin formulations
AU2003300666A1 (en) * 2002-12-20 2004-07-29 Botulinum Toxin Research Associates, Inc. Pharmaceutical botulinum toxin compositions
PT1677806E (pt) 2003-10-09 2009-01-29 Robert John Petrella Métodos para tratamento de entorse e distensão muscular aguda e por excesso de esforço utilizando ácido hialurónico
WO2006011109A1 (en) * 2004-07-22 2006-02-02 Philips Intellectual Property & Standards Gmbh Scheduling the transmission of messages on a broadcast channel of an ad-hoc network dependent on the usage of this channel
BRPI0513850A (pt) 2004-07-26 2008-05-20 Merz Pharma Gmbh & Co Kgaa composição terapêutica com uma neurotoxina botulìnica
EP1853303B1 (en) * 2005-02-14 2015-12-02 DPM Therapeutics Corporation Stabilized compositions for topical administration and methods of making same
FR2896693B1 (fr) 2006-01-27 2008-03-14 Sod Conseils Rech Applic Composition comprenant plusieurs toxines botuliques

Similar Documents

Publication Publication Date Title
JP2012514579A5 (enExample)
Choi et al. Enhanced recovery after surgery for major orthopedic surgery: a narrative review
JP2014205721A5 (enExample)
Chiong et al. Randomized controlled study of mechanical percussion, diuresis, and inversion therapy to assist passage of lower pole renal calculi after shock wave lithotripsy
Mun et al. Clinical efficacy of hydrodistention with joint manipulation under interscalene block compared with intra-articular corticosteroid injection for frozen shoulder: a prospective randomized controlled study
Zewin et al. Efficacy and safety of low-intensity shock wave therapy in penile rehabilitation post nerve-sparing radical cystoprostatectomy: a randomized controlled trial
Wu et al. Perioperative multiple low-dose Dexamethasones improves postoperative clinical outcomes after Total knee arthroplasty
Armagan et al. Effects of placebo-controlled continuous and pulsed ultrasound treatments on carpal tunnel syndrome: a randomized trial
WO2011041632A3 (en) Combination therapies for the treatment of obesity
CA2541813A1 (en) Methods for treating acute and overuse sprain and strain using hyaluronic acid
Pajareya et al. Effectiveness of physical therapy for patients with adhesive capsulitis: a randomized controlled trial
WO2010045417A3 (en) Combination therapies for the treatment of obesity
WO2010151503A3 (en) Combination therapies for the treatment of obesity
Pourmand et al. Tamsulosin for urolithiasis: a review of the recent literature and current controversies
Van Leemput et al. Distal metaphyseal radius fractures in children: reduction with or without pinning.
Mohamed The efficacy of tamsulosin therapy after extracorporeal shock-wave lithotripsy for ureteric calculi: a prospective randomised, controlled study
Taylor et al. Non‐surgical therapy of Peyronie's disease
Eun The diagnosis and treatment of plantar fasciitis
Kumar et al. An observational study to compare the outcome of local steroid injections and ultrasonic wave therapy in frozen shoulder patients
CN118924729A (zh) 金缕梅丹宁在制备治疗肌肉萎缩疾病药物中的应用
Kuehl et al. Analgesic efficacy and safety of the diclofenac epolamine topical patch 1.3%(DETP) in minor soft tissue injury
RU2585744C1 (ru) Способ лечения разгибательной контрактуры локтевого сустава у детей с артрогрипозом
WO2011008490A3 (en) Combination therapies for the treatment of obesity
Deshpande et al. Heel pain and phonophoresis
JP5009152B2 (ja) 放射線誘発性腸炎の予防、処置、および回復